Eden Research plc Net Assets
Eden Research plc net assets. Based on the latest financial reports, Eden Research plc (EDEN) has net assets worth GBX10.61 Million GBX (≈ $1.29K USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX13.46 Million ≈ $1.64K USD) and total liabilities (GBX2.85 Million ≈ $347.13 USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore EDEN net assets growth trend to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | GBX10.61 Million |
| % of Total Assets | 78.81% |
| Annual Growth Rate | 1.54% |
| 5-Year Change | -3.11% |
| 10-Year Change | 83.79% |
| Growth Volatility | 37.38 |
Net Assets of Eden Research plc (2004–2026)
Net assets of Eden Research plc from 2004 to 2026. This chart illustrates how Eden Research plc's net assets have evolved over time, based on quarterly financial data. See how leveraged is Eden Research plc's balance sheet to measure how much of total assets are equity-financed.
Annual Net Assets for Eden Research plc (2004–2026)
The table below shows the annual net assets of Eden Research plc from 2004 to 2026. For live market cap and overall valuation, see market cap of Eden Research plc.
| Year | Net Assets | Change |
|---|---|---|
| 2026-03-31 | GBX12.43 Million ≈ $1.51K |
+5.01% |
| 2024-12-31 | GBX11.84 Million ≈ $1.44K |
-12.61% |
| 2023-12-31 | GBX13.55 Million ≈ $1.65K |
+26.09% |
| 2022-12-31 | GBX10.74 Million ≈ $1.31K |
-16.26% |
| 2021-12-31 | GBX12.83 Million ≈ $1.56K |
-14.06% |
| 2020-12-31 | GBX14.93 Million ≈ $1.82K |
+103.18% |
| 2019-12-31 | GBX7.35 Million ≈ $894.00 |
-11.23% |
| 2018-12-31 | GBX8.28 Million ≈ $1.01K |
-2.78% |
| 2017-12-31 | GBX8.51 Million ≈ $1.04K |
+25.89% |
| 2016-12-31 | GBX6.76 Million ≈ $822.88 |
+14.11% |
| 2015-12-31 | GBX5.93 Million ≈ $721.13 |
-0.27% |
| 2014-12-31 | GBX5.94 Million ≈ $723.09 |
+4.64% |
| 2013-12-31 | GBX5.68 Million ≈ $691.04 |
+3.12% |
| 2012-12-31 | GBX5.51 Million ≈ $670.17 |
+2.27% |
| 2011-12-31 | GBX5.39 Million ≈ $655.32 |
+106.92% |
| 2010-12-31 | GBX2.60 Million ≈ $316.71 |
-45.27% |
| 2009-12-31 | GBX4.76 Million ≈ $578.67 |
-9.47% |
| 2008-12-31 | GBX5.25 Million ≈ $639.22 |
-14.72% |
| 2007-12-31 | GBX6.16 Million ≈ $749.53 |
+41.28% |
| 2006-12-31 | GBX4.36 Million ≈ $530.54 |
-31.85% |
| 2005-12-31 | GBX6.40 Million ≈ $778.44 |
-28.72% |
| 2004-12-31 | GBX8.98 Million ≈ $1.09K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Eden Research plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 170237300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Eden Research plc Net Assets Breakdown (March 2026)
Eden Research plc net assets breakdown by equity component as of March 2026.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | GBX6.13 Million | 49.40% |
| Other Comprehensive Income | GBX530.27K | 4.27% |
| Other Components | GBX8.54 Million | 68.79% |
| Total Equity | GBX12.42 Million | 100.00% |
Eden Research plc Competitors by Market Cap
The table below lists competitors of Eden Research plc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Krakchemia SA
WAR:KCH
|
$333.15K |
|
PUNCH PUNK S.A. ZY-10
F:6K7
|
$333.63K |
|
Southstone Minerals Ltd
V:SML
|
$334.02K |
|
LeddarTech Holdings Inc
NASDAQ:LDTC
|
$334.76K |
|
Duearity AB
ST:DEAR
|
$331.97K |
|
Tortilla Mexican Grill PLC
LSE:MEX
|
$331.65K |
|
Challenger Energy Group PLC
LSE:CEG
|
$331.01K |
|
Blaize Holdings, Inc. Warrants
NASDAQ:BZAIW
|
$330.55K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Eden Research plc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2026, total equity changed from 11,817,319 to 12,415,256, a change of 597,937 (5.1%).
- Net loss of 1,957,518 reduced equity.
- Other comprehensive income decreased equity by 259,879.
- Other factors increased equity by 2,815,334.
Equity Change Factors (2024 to 2026)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | GBX-1.96 Million | -15.77% |
| Other Comprehensive Income | GBX-259.88K | -2.09% |
| Other Changes | GBX2.82 Million | +22.68% |
| Total Change | GBX- | 5.06% |
Book Value vs Market Value Analysis
This analysis compares Eden Research plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 148.91x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 16.65x to 148.91x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2004-12-31 | GBX0.20 | GBX3.40 | x |
| 2005-12-31 | GBX0.14 | GBX3.40 | x |
| 2006-12-31 | GBX0.10 | GBX3.40 | x |
| 2007-12-31 | GBX0.13 | GBX3.40 | x |
| 2008-12-31 | GBX0.10 | GBX3.40 | x |
| 2009-12-31 | GBX0.04 | GBX3.40 | x |
| 2010-12-31 | GBX0.02 | GBX3.40 | x |
| 2011-12-31 | GBX0.06 | GBX3.40 | x |
| 2012-12-31 | GBX0.05 | GBX3.40 | x |
| 2013-12-31 | GBX0.05 | GBX3.40 | x |
| 2014-12-31 | GBX0.05 | GBX3.40 | x |
| 2015-12-31 | GBX0.04 | GBX3.40 | x |
| 2016-12-31 | GBX0.04 | GBX3.40 | x |
| 2017-12-31 | GBX0.04 | GBX3.40 | x |
| 2018-12-31 | GBX0.04 | GBX3.40 | x |
| 2019-12-31 | GBX0.04 | GBX3.40 | x |
| 2020-12-31 | GBX0.04 | GBX3.40 | x |
| 2021-12-31 | GBX0.03 | GBX3.40 | x |
| 2022-12-31 | GBX0.03 | GBX3.40 | x |
| 2023-12-31 | GBX0.03 | GBX3.40 | x |
| 2024-12-31 | GBX0.02 | GBX3.40 | x |
| 2026-03-31 | GBX0.02 | GBX3.40 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Eden Research plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -15.77%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -50.43%
- • Asset Turnover: 0.24x
- • Equity Multiplier: 1.32x
- Recent ROE (-15.77%) is above the historical average (-36.07%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2004 | -25.57% | -6656.04% | 0.00x | 1.13x | GBX-3.19 Million |
| 2005 | -40.29% | 0.00% | 0.00x | 1.35x | GBX-3.22 Million |
| 2006 | -93.85% | -3990.22% | 0.01x | 1.74x | GBX-4.53 Million |
| 2007 | -40.00% | -682.91% | 0.04x | 1.45x | GBX-3.08 Million |
| 2008 | -40.00% | -2501.38% | 0.01x | 1.63x | GBX-2.63 Million |
| 2009 | -36.31% | -894.82% | 0.02x | 1.87x | GBX-2.20 Million |
| 2010 | -124.89% | -1890.12% | 0.02x | 3.18x | GBX-3.51 Million |
| 2011 | -60.97% | -3608.79% | 0.01x | 1.54x | GBX-3.82 Million |
| 2012 | -42.07% | -5315.75% | 0.01x | 1.38x | GBX-2.87 Million |
| 2013 | -27.96% | -1979.37% | 0.01x | 1.15x | GBX-2.16 Million |
| 2014 | -49.97% | -2973.78% | 0.02x | 1.08x | GBX-3.56 Million |
| 2015 | -19.52% | -131.00% | 0.13x | 1.13x | GBX-1.75 Million |
| 2016 | -27.07% | -467.17% | 0.05x | 1.15x | GBX-2.51 Million |
| 2017 | -7.51% | -34.05% | 0.18x | 1.24x | GBX-1.49 Million |
| 2018 | -4.05% | -12.07% | 0.30x | 1.11x | GBX-1.16 Million |
| 2019 | -15.61% | -62.71% | 0.21x | 1.21x | GBX-1.88 Million |
| 2020 | -15.23% | -165.84% | 0.08x | 1.14x | GBX-3.76 Million |
| 2021 | -21.79% | -227.01% | 0.08x | 1.17x | GBX-4.07 Million |
| 2022 | -20.87% | -122.44% | 0.14x | 1.20x | GBX-3.31 Million |
| 2023 | -48.04% | -203.45% | 0.19x | 1.23x | GBX-7.85 Million |
| 2024 | -16.13% | -44.31% | 0.28x | 1.30x | GBX-3.09 Million |
| 2026 | -15.77% | -50.43% | 0.24x | 1.32x | GBX-3.20 Million |
Industry Comparison
This section compares Eden Research plc's net assets metrics with peer companies in the Agricultural Inputs industry.
Industry Context
- Industry: Agricultural Inputs
- Average net assets among peers: $37,194,527
- Average return on equity (ROE) among peers: -3.87%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Eden Research plc (EDEN) | GBX10.61 Million | -25.57% | 0.27x | $332.34K |
| Emmerson PLC (EML) | $957.11K | -26.02% | 0.05x | $162.60K |
| Harvest Minerals Ltd (HMI) | $1.73 Million | 0.00% | 0.05x | $13.77K |
| Kropz Plc (KRPZ) | $134.83 Million | -1.43% | 0.41x | $80.87K |
| Wynnstay Group Plc (WYN) | $11.26 Million | 11.95% | 1.03x | $980.28K |
About Eden Research plc
Eden Research plc, together with its subsidiaries, biopesticides and plastic-free encapsulation technology for use in the global crop protection, animal health, and consumer products industries in Europe and the United Kingdom. The company offers foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatments under the Mevalone and… Read more